Kelly W. Burak

1 ta ish

University of Calgary

1. 49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL

   Jordi Bruix, Thierry Poynard, Massimo Colombo +16

   MaqolaOAOchiq kirishHepatocellular Carcinoma Treatment and PrognosisJournal of Hepatology20090 iqtibos

   ABIABI:AkademIndex/2009.article.000125